Copyright: ©Author(s) 2026.
World J Transl Med. Sep 28, 2026; 12(3): 121879
Published online Sep 28, 2026. doi: 10.5528/wjtm.121879
Published online Sep 28, 2026. doi: 10.5528/wjtm.121879
Figure 1 Platelet-mediated immunothrombosis and the role of antiplatelet therapy in pulmonary embolism.
C3a: Complement component 3a; C5a: Complement component 5a; NET: Neutrophil extracellular trap; P2Y12: Platelet purinergic P2Y12 receptor; PE: Pulmonary embolism; PSGL-1: P-selectin glycoprotein ligand 1; RBCs: Red blood cells; Xa: Activated coagulation factor X.
- Citation: Kalamara TV, Dodos K, Georgakopoulou VE. Antiplatelet therapy in pulmonary embolism: Mechanisms and evidence. World J Transl Med 2026; 12(3): 121879
- URL: https://www.wjgnet.com/2220-6132/full/v12/i3/121879.htm
- DOI: https://dx.doi.org/10.5528/wjtm.121879